Negative regulation of actin nucleation

pathway activity — cross-omics
GO:0051126Cross-omicsPROTEIN-MS → RNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Negative regulation of actin nucleation pathway is significantly associated with the RNA expression of multiple genes, with the BLOOD_Myeloma cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are RIPK3, VAMP8, and C1R, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of actin nucleation activity versus RIPK3 in BLOOD_Myeloma (Pearson r = 0.65).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_MyelomaRIPK3 →+2.202+0.221<.001.00835
BLOOD_LeukemiaVAMP8 →+2.718+0.175<.001<.00135
LUNG_NSCLC_LUADC1R →-2.617-0.775<.001.00335
BLOOD_LeukemiaARRDC1 →+1.308+0.241<.001<.00135
BLOOD_LeukemiaSLC16A1 →-0.911-0.177<.001.00335
LUNG_NSCLC_LUADCRB3 →+2.082+0.571.001.00334
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0051126 vs RIPK3 — BLOOD_Myeloma

Per-sample scatter of Negative regulation of actin nucleation activity vs RIPK3 in BLOOD_Myeloma.

Explore this scatter interactively →

Exploration